Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan probe study of tamoxifen pharmacokinetics
NL-OMON33769Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tamoxifen and dextromethorphan in breast cancer, sponsored by Erasmus MC. Primary endpoint: Relationship between tamoxifen and dextromethorphan clearance. Started Jun 2009; status: active, not recruiting.
02
Drugs
tamoxifendextromethorphan
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON33769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33769.